BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23236990)

  • 1. Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis.
    Serce NB; Boesl A; Klaman I; von Serényi S; Noetzel E; Press MF; Dimmler A; Hartmann A; Sehouli J; Knuechel R; Beckmann MW; Fasching PA; Dahl E
    BMC Cancer; 2012 Dec; 12():597. PubMed ID: 23236990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer.
    Bektas N; Noetzel E; Veeck J; Press MF; Kristiansen G; Naami A; Hartmann A; Dimmler A; Beckmann MW; Knüchel R; Fasching PA; Dahl E
    Breast Cancer Res; 2008; 10(4):R58. PubMed ID: 18627608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.
    Bektas N; Haaf At; Veeck J; Wild PJ; Lüscher-Firzlaff J; Hartmann A; Knüchel R; Dahl E
    BMC Cancer; 2008 Feb; 8():42. PubMed ID: 18254960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
    Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
    Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
    Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
    BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival.
    Li J; Zhang N; Song LB; Liao WT; Jiang LL; Gong LY; Wu J; Yuan J; Zhang HZ; Zeng MS; Li M
    Clin Cancer Res; 2008 Jun; 14(11):3319-26. PubMed ID: 18519759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival.
    ten Haaf A; Bektas N; von Serenyi S; Losen I; Arweiler EC; Hartmann A; Knüchel R; Dahl E
    BMC Cancer; 2009 Aug; 9():298. PubMed ID: 19706168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.
    Dahl E; En-Nia A; Wiesmann F; Krings R; Djudjaj S; Breuer E; Fuchs T; Wild PJ; Hartmann A; Dunn SE; Mertens PR
    BMC Cancer; 2009 Nov; 9():410. PubMed ID: 19930682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
    Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
    Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression status of cyclase‑associated protein 2 as a prognostic marker for human breast cancer.
    Xu L; Peng S; Huang Q; Liu Y; Jiang H; Li X; Wang J
    Oncol Rep; 2016 Oct; 36(4):1981-8. PubMed ID: 27573674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.
    Wei CY; Tan QX; Zhu X; Qin QH; Zhu FB; Mo QG; Yang WP
    Int J Clin Exp Pathol; 2015; 8(11):14619-29. PubMed ID: 26823785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.
    O Leary PC; Penny SA; Dolan RT; Kelly CM; Madden SF; Rexhepaj E; Brennan DJ; McCann AH; Pontén F; Uhlén M; Zagozdzon R; Duffy MJ; Kell MR; Jirström K; Gallagher WM
    BMC Cancer; 2013 Apr; 13():175. PubMed ID: 23547718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype.
    Grelier G; Voirin N; Ay AS; Cox DG; Chabaud S; Treilleux I; Léon-Goddard S; Rimokh R; Mikaelian I; Venoux C; Puisieux A; Lasset C; Moyret-Lalle C
    Br J Cancer; 2009 Aug; 101(4):673-83. PubMed ID: 19672267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclin kinase subunit 2 in human breast cancer and its prognostic significance.
    Wang J; Xu L; Liu Y; Chen J; Jiang H; Yang S; Tan H
    Int J Clin Exp Pathol; 2014; 7(12):8593-601. PubMed ID: 25674223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.
    Hildenbrand R; Schaaf A; Dorn-Beineke A; Allgayer H; Sütterlin M; Marx A; Stroebel P
    Histol Histopathol; 2009 Jul; 24(7):869-77. PubMed ID: 19475533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.
    Guo K; Zheng S; Xu Y; Xu A; Chen B; Wen Y
    Tumour Biol; 2016 Sep; 37(9):12843-12854. PubMed ID: 27449037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer.
    Schröder C; Witzel I; Müller V; Krenkel S; Wirtz RM; Jänicke F; Schumacher U; Milde-Langosch K
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1193-201. PubMed ID: 21590495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.
    Deng Q; Yang H; Lin Y; Qiu Y; Gu X; He P; Zhao M; Wang H; Xu Y; Lin Y; Jiang J; He J; Zhou JX
    Int J Clin Exp Pathol; 2014; 7(12):8312-21. PubMed ID: 25674197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome.
    Pare R; Shin JS; Lee CS
    Histopathology; 2016 Sep; 69(3):479-91. PubMed ID: 26843058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.